RxDoctor Payments DataLook up a doctor →

Cathy Naughton, MD

Urology · Chesterfield, MONPI 1912923228

Payments from drug & device makers

$29,647in general payments, 2019–2025

Across 658 payments — averaging $45.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Teleflex LLC$6K
  • Axonics, Inc.$2K
  • Boston Scientific$2K
  • Coloplast$2K
  • Neotract Inc.$2K
  • plus $8K from 47 others
$710in research payments, 2019–2025

Across 1 payment — averaging $710.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$710

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)131$7,597
Teleflex LLC47$5,855
Axonics, Inc.39$2,426
Boston Scientific55$2,374
Coloplast32$2,047
Neotract Inc.41$1,830
Endo Pharmaceuticals Inc.84$1,452
Astellas Pharma US Inc34$854
Calyxo, Inc.10$701
AbbVie(2 entities)32$472
Antares Pharma, Inc.17$403
Stimwave Technologies Incorporated3$364
Sumitomo Pharma America, Inc.23$362
C. R. Bard, Inc. & Subsidiaries15$292
Urovant Sciences Inc11$246
Laborie Medical Technologies Corp.4$217
Myriad Genetic Laboratories, Inc.6$212
Johnson & Johnson10$211
Endo USA, Inc.9$199
Urogen Pharma, Inc.3$168
SRS Medical Systems, Inc.3$134
Olympus America Inc.5$126
Uroviu Corporation1$111
Innovation Technologies Inc1$95
Convatec Inc.2$62
Astellas Pharma Global Development1$60
BD3$53
Procept Biorobotics Corporation2$49
Pfizer2$45
Cumberland Pharmaceuticals, Inc.3$44
180 Medical, Inc.2$43
Sanofi2$39
Ambu Inc.1$37
Baxter Healthcare1$36
Blue Earth Diagnostics2$34
Acerus Pharmaceuticals Corporation2$32
Azurity Pharmaceuticals, Inc.2$32
Rochester Medical Corporation2$30
Ferring Pharmaceuticals Inc.1$25
Progenics Pharmaceuticals, Inc.1$25
Travere Therapeutics, Inc.1$25
Novartis1$25
Inspire Medical Systems, Inc.1$22
AstraZeneca1$22
Bayer1$21
Tolmar Pharmaceuticals, Inc.1$21
Aytu Biopharma, Inc.1$21
Novo Nordisk1$20
Halozyme Inc1$18
Civco Medical Instruments1$16
Cook Medical LLC1$15
Tolmar, Inc.1$15
Sanofi-aventis U.S. LLC1$13

How this compares

$29,647 in reported general payments places this provider in the 90th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri →

Medicare billing

Part B allowed, 2024
$332,417
Medicare patients
509
Services billed
11,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Chesterfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →